Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Tips from these results
Recent Share tips:
- Buy Liontrust Asset Management (LIO) by Stephen Bhasera in The Motley Fool
- Buy OptiBiotix Health (OPTI) by Tom Winnifrith in ShareProphets
- Strong Buy KEFI Gold and Copper (KEFI) by Hot Stock Rockets in ShareProphets
- Sell Tern (TERN) by Tom Winnifrith in ShareProphets
- Buy Darktrace (DARK) by James Reynolds in The Motley Fool
- Buy Wise Class A (WISE) by James Reynolds in The Motley Fool
- Buy JD Sports Fashion (JD.) by James Reynolds in The Motley Fool
- Buy Persimmon (PSN) by Zaven Boyrazian in The Motley Fool
- Buy Assura (AGR) by Royston Wild in The Motley Fool
- Buy Restaurant Group (RTN) by Royston Wild in The Motley Fool
- Buy The City Pub Group (CPC) by Royston Wild in The Motley Fool
- Watch DigitalBox (DBOX) by Steve Moore in ShareProphets
- Overweight JD Sports Fashion (JD.) by JP Morgan
- Outperform JD Sports Fashion (JD.) by Credit Suisse
- Buy Halfords Group (HFD) by Dan Appleby in The Motley Fool
- Neutral Wizz Air Holdings (WIZZ) by UBS
- Buy Glencore (GLEN) by Goldman Sachs
- Buy Liontrust Asset Management (LIO) by Dan Appleby in The Motley Fool
- Sell Tern (TERN) by Nigel Somerville in ShareProphets
- Buy Belvoir Group (BLV) by Dan Appleby in The Motley Fool
Vectura Group (VEC)
Health Care Sector
| Latest Bid : – | Latest Ask : – |
| High Today : – | Low Today : – |
| This Years High : – | This Years Low : – |
| Volume : – | MKT Cap : – |
Vectura Group Overview
Vectura develops inhaled therapies principally for the treatment of respiratory diseases. Inhaled formulation development is increasingly complex with a wide variety of small molecules and biologics, increasing use of combination products and the need for targeted lung delivery or deep lung deposition for systemic delivery. We offer formulation services for DPI, pMDI and nebuliser development, including small molecules and biologics, complex combinations and generic products.Latest Vectura Group Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| – | Peel Hunt | – | 2021-07-09 10:25:00 09/07/2021 | – |
| – | Shore Capital | – | 2021-05-26 18:00:00 26/05/2021 | – |
| – | Panmure Gordon | – | 2021-05-26 14:25:00 26/05/2021 | – |
| – | Peel Hunt | – | 2021-05-26 11:10:00 26/05/2021 | – |
| – | JP Morgan | – | 2021-03-19 07:30:00 19/03/2021 | – |
| Latest Bid : – | Latest Ask : – |
| High Today : – | Low Today : – |
| This Years High : – | This Years Low : – |
| Volume : – | MKT Cap : – |
Vectura Group Overview
Vectura develops inhaled therapies principally for the treatment of respiratory diseases. Inhaled formulation development is increasingly complex with a wide variety of small molecules and biologics, increasing use of combination products and the need for targeted lung delivery or deep lung deposition for systemic delivery. We offer formulation services for DPI, pMDI and nebuliser development, including small molecules and biologics, complex combinations and generic products.Latest Vectura Group Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| – | Peel Hunt | – | 2021-07-09 10:25:00 09/07/2021 | – |
| – | Shore Capital | – | 2021-05-26 18:00:00 26/05/2021 | – |
| – | Panmure Gordon | – | 2021-05-26 14:25:00 26/05/2021 | – |
| – | Peel Hunt | – | 2021-05-26 11:10:00 26/05/2021 | – |
| – | JP Morgan | – | 2021-03-19 07:30:00 19/03/2021 | – |